The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

They were then asked to measure a 5 mL (1 teaspoon) dose of Tylenol (acetaminophen) suspension, using the EZY Dose oral syringe and the dosing cup provided by the manufacturer. An acceptable dose ...

Vibration anesthesia during botulinum toxin injections for masseter reduction is a safe and effective option for pain management.

LONDON, GREATER LONDON, UNITED KINGDOM, January 28, 2025 /EINPresswire / -- How Has the Hizentra Market Performed Historically, and What Does the Future Hold? The hizentra market size has seen ...

In the case of the 5 ml SCHOTT TOPPAC® infuse, eliminating blisters allows an additional 1,260 syringes per pallet to be shipped, resulting in 16 containers saved per ten million syringes. In addition ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...

Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark–approved COBRA-OS—Control ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...